Chordia Therapeutics Inc. (JP:190A) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Chordia Therapeutics Inc. reports a net loss of 1,177 million yen for the nine months ending May 31, 2024, with a significant decrease in net assets from the previous period. Despite the financial downturn, the company’s equity ratio remains high at 95.2%. No dividends have been announced, and the company cautions that actual financial results may vary from forecasts.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.